Phreesia Inc
$ 9.06
0.11%
12 Jun - close price
- Market Cap 559,675,000 USD
- Current Price $ 9.06
- High / Low $ 9.13 / 8.77
- Stock P/E 56.62
- Book Value 5.81
- EPS 0.16
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE 0.03 %
- 52 Week High 32.76
- 52 Week Low 7.77
About
Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.
Analyst Target Price
$13.94
Quarterly Earnings
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-27 | 2026-03-30 | 2025-12-08 | 2025-09-04 | 2025-05-28 | 2025-03-12 | 2024-12-09 | 2024-09-04 | 2024-05-30 | 2024-03-14 | 2023-12-05 | 2023-09-06 |
| Reported EPS | 0.1872 | 0.4404 | 0.07 | 0.01 | 0.2259 | 0.1848 | 0.0367 | -0.31 | -0.35 | -0.21 | -0.25 | -0.34 |
| Estimated EPS | 0.2884 | 0.0614 | -0.0014 | -0.06 | -0.42 | 0.1106 | -0.27 | -0.36 | -0.48 | -0.26 | -0.36 | -0.42 |
| Surprise | -0.1012 | 0.379 | 0.0714 | 0.07 | 0.6459 | 0.0742 | 0.3067 | 0.05 | 0.13 | 0.05 | 0.11 | 0.08 |
| Surprise Percentage | -35.0902% | 617.2638% | 5100% | 116.6667% | 153.7857% | 67.0886% | 113.5926% | 13.8889% | 27.0833% | 19.2308% | 30.5556% | 19.0476% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PHR
2026-06-14 15:39:40
Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) and certain officers, alleging federal securities law violations. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments between May 8, 2025, and March 30, 2026. Investors who suffered losses are encouraged to join the case and have until July 13, 2026, to request lead plaintiff status.
2026-06-13 18:11:05
Faruqi & Faruqi, LLP is reminding investors of Phreesia (NYSE: PHR) about a securities class action lawsuit with a lead plaintiff deadline of July 13, 2026. The lawsuit alleges that Phreesia made misleading statements regarding its growth potential and concealed slowing demand and reduced visibility in key revenue streams, leading to a significant stock price decline. Investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, and suffered losses are encouraged to contact the firm.
2026-06-12 18:39:39
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers, inviting shareholders who incurred losses between May 8, 2025, and March 30, 2026, to join. The lawsuit alleges that Phreesia made false and misleading statements about slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors have until July 13, 2026, to apply for lead plaintiff status.
2026-06-12 15:39:39
The Gross Law Firm is reminding shareholders of Phreesia, Inc. (NYSE: PHR) who purchased shares between May 8, 2025, and March 30, 2026, about a lead plaintiff deadline of July 13, 2026, in a class action lawsuit. The lawsuit alleges that Phreesia disseminated false and misleading statements regarding slowing demand and reduced visibility in key revenue streams, particularly pharmaceutical marketing commitments. This led to a significant stock price decline after the company announced reduced revenue growth projections for fiscal year 2027.
2026-06-12 07:45:00
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who suffered losses due to alleged securities fraud between May 8, 2025, and March 30, 2026. The lawsuit claims Phreesia made misleading statements about its financial health, concealing slowing demand and reduced visibility in key revenue streams, especially weakened pharmaceutical marketing commitments. This led to a significant stock price drop after the company announced reduced revenue growth projections for fiscal year 2027.
2026-06-11 16:12:32
Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against Phreesia Inc. (PHR), inviting investors who incurred losses to lead the action. The lawsuit alleges that Phreesia created a false impression regarding its long-term growth outlook and minimized risks concerning its Network Solutions segment's growth. The deadline for investors to participate as a lead plaintiff is July 13, 2026.
